Add to ORKGit Pancreatic cancer (PC) is a devastating disease. Gemcitabine has been the standard therapy for experimental regimens terations. During early genetic events, such as activating point mutations in the K-ras oncogene and the overex-Togashi et al. Molecular Cancer 2014, 13:12
Pancreatic cancer remains a formidable challenge for oncologists and patients alike. Despite intensi...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes of cancer-related death all...
Abstract Cancer of the exocrine pancreas represents the fifth leading cause of cancer death in the W...
The treatment of advanced pancreatic cancer has not moved much beyond single agent gemcitabine until...
Chemotherapy has produced unsatisfactory results in pancreas cancer and novel approaches, including ...
Despite the extensive research, mounting knowledge in the cancer field and enormous investments, pan...
Metastasis and drug resistance are the major causes of mortality in patients with pancreatic cancer....
Pancreatic cancer is the fourth leading cause of cancer death in our society, with a mortality that ...
Pancreatic cancer (PC) is a lethal disease with marked genetic heterogeneity. There is an immediate...
Pancreatic cancer is a deadly disease and the third-highest cause of cancer-related deaths in the Un...
Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is a...
<div> Pancreatic cancer (PC) is a progressive, fatal disease with a high degree of malignancy. More ...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult to treat major cancers, wi...
The aim of our work was to identify the genes specifically altered in pancreatic adenocarcinoma and ...
International audienceThe understanding of the biology of pancreatic carcinoma has greatly benefited...
Pancreatic cancer remains a formidable challenge for oncologists and patients alike. Despite intensi...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes of cancer-related death all...
Abstract Cancer of the exocrine pancreas represents the fifth leading cause of cancer death in the W...
The treatment of advanced pancreatic cancer has not moved much beyond single agent gemcitabine until...
Chemotherapy has produced unsatisfactory results in pancreas cancer and novel approaches, including ...
Despite the extensive research, mounting knowledge in the cancer field and enormous investments, pan...
Metastasis and drug resistance are the major causes of mortality in patients with pancreatic cancer....
Pancreatic cancer is the fourth leading cause of cancer death in our society, with a mortality that ...
Pancreatic cancer (PC) is a lethal disease with marked genetic heterogeneity. There is an immediate...
Pancreatic cancer is a deadly disease and the third-highest cause of cancer-related deaths in the Un...
Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is a...
<div> Pancreatic cancer (PC) is a progressive, fatal disease with a high degree of malignancy. More ...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult to treat major cancers, wi...
The aim of our work was to identify the genes specifically altered in pancreatic adenocarcinoma and ...
International audienceThe understanding of the biology of pancreatic carcinoma has greatly benefited...
Pancreatic cancer remains a formidable challenge for oncologists and patients alike. Despite intensi...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes of cancer-related death all...
Abstract Cancer of the exocrine pancreas represents the fifth leading cause of cancer death in the W...